areteiatx.comHealthcareFounded: 2022Funding to Date: $175MM
Areteia Therapeutics is a clinical stage biotechnology company focused on oral asthma drug development.
For more details on financing and valuation for Areteia Therapeutics, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Areteia Therapeutics.
To read this article and more news on Areteia Therapeutics, register or login.
